Enrolling By Invitation INTERVENTIONAL NCT07476807

Telemedicine Rash Evaluation and Assessment of Toxicity in Skin in Acute Oncology and Haematology Care: A Pilot Study (TREATS)

TREATS: Telemedicine Rash Evaluation and Assessment of Toxicity in Skin in Acute Oncology and Haematology Care: A Pilot Study

Sponsor: Sligo General Hospital

Conditions Rash Systemic Treatments Tele-assessment

Interventions telem healthassessment

Updated 1 time since 2026 Last updated: Apr 22, 2026 Started: Apr 1, 2026 Primary completion: Apr 1, 2026 Completion: Sep 12, 2026

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Rash and Systemic Treatments and is currently ongoing. Sligo General Hospital leads this study, which shows 1 recorded version since 2026 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

1 version recorded

Enrolling By Invitation [daily]

Eligibility Summary

This study is being done to find out if video consultations (telemedicine) can be used to safely and effectively assess and manage skin problems caused by cancer treatments. Instead of always coming to the hospital for a face-to-face appointment, the patient may be able to use thier smartphone or computer to show your skin to a nurse or doctor over a secure video call. the researchers want to see if this is as good as a regular clinic visit, and whether patients and staff are happy with this new way of working.

Contact Information

Sponsor contact:

Sligo General Hospital

Data source: ClinicalTrials.gov

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Sligo, Ireland